ILLUMINA, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2010 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Illumina, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2010 to Q3 2024.
  • Illumina, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 159M shares, a 0.13% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 159M -200K -0.13% Nov 1, 2024 10-Q 2024-11-06
Q2 2024 159M +1M +0.63% Aug 2, 2024 10-Q 2024-08-07
Q1 2024 159M +1.2M +0.76% Apr 26, 2024 10-Q 2024-05-03
Q4 2023 159M +900K +0.57% Feb 9, 2024 10-K 2024-02-16
Q3 2023 159M +1.5M +0.95% Nov 6, 2023 10-Q 2023-11-13
Q2 2023 158M +1M +0.64% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 158M +1M +0.64% Apr 28, 2023 10-Q 2023-05-05
Q4 2022 158M +1M +0.64% Feb 10, 2023 10-K 2023-02-17
Q3 2022 157M +1M +0.64% Oct 28, 2022 10-Q 2022-11-04
Q2 2022 157M +10.6M +7.23% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 157M +11.1M +7.6% Apr 29, 2022 10-Q 2022-05-05
Q4 2021 157M +11.1M +7.61% Feb 11, 2022 10-K 2022-02-18
Q3 2021 156M +10.3M +7.06% Oct 29, 2021 10-Q 2021-11-05
Q2 2021 147M +700K +0.48% Jul 30, 2021 10-Q 2021-08-06
Q1 2021 146M -1M -0.68% Apr 23, 2021 10-Q 2021-04-28
Q4 2020 146M -1.1M -0.75% Feb 12, 2021 10-K 2021-02-17
Q3 2020 146M -1M -0.68% Oct 23, 2020 10-Q 2020-10-30
Q2 2020 146M -1M -0.68% Jul 31, 2020 10-Q 2020-08-07
Q1 2020 147M 0 0% Apr 24, 2020 10-Q 2020-05-01
Q4 2019 147M 0 0% Feb 7, 2020 10-K 2020-02-11
Q3 2019 147M 0 0% Oct 18, 2019 10-Q 2019-10-25
Q2 2019 147M 0 0% Jul 26, 2019 10-Q 2019-07-31
Q1 2019 147M 0 0% Apr 18, 2019 10-Q 2019-04-26
Q4 2018 147M 0 0% Feb 8, 2019 10-K 2019-02-12
Q3 2018 147M +1M +0.69% Oct 19, 2018 10-Q 2018-10-24
Q2 2018 147M +1M +0.69% Jul 27, 2018 10-Q 2018-07-31
Q1 2018 147M +1M +0.69% Apr 20, 2018 10-Q 2018-04-25
Q4 2017 147M +700K +0.48% Feb 9, 2018 10-K 2018-02-13
Q3 2017 146M -900K -0.61% Oct 20, 2017 10-Q 2017-10-25
Q2 2017 146M -600K -0.41% Jul 28, 2017 10-Q 2017-08-03
Q1 2017 146M -1.2M -0.82% Apr 21, 2017 10-Q 2017-05-05
Q4 2016 146M Feb 3, 2017 10-K 2017-02-14
Q3 2016 147M +500K +0.34% Oct 21, 2016 10-Q 2016-11-08
Q2 2016 147M +1.9M +1.31% Jul 22, 2016 10-Q 2016-08-02
Q1 2016 147M +3.1M +2.15% Apr 29, 2016 10-Q 2016-05-09
Q3 2015 146M +4.4M +3.1% Oct 8, 2015 10-Q 2015-11-02
Q2 2015 145M +5.3M +3.8% Jul 9, 2015 10-Q 2015-07-31
Q1 2015 144M +15.7M +12.2% Apr 10, 2015 10-Q 2015-05-01
Q4 2014 144M +15.6M +12.2% Jan 30, 2015 10-K 2015-02-18
Q3 2014 142M +15.6M +12.3% Oct 8, 2014 10-Q 2014-10-29
Q2 2014 139M +14.3M +11.4% Jul 10, 2014 10-Q 2014-08-01
Q1 2014 128M +4.02M +3.23% Apr 11, 2014 10-Q 2014-05-07
Q4 2013 128M +4.16M +3.35% Jan 31, 2014 10-K 2014-02-18
Q3 2013 126M +3.01M +2.44% Oct 9, 2013 10-Q 2013-11-06
Q2 2013 125M +2.13M +1.73% Jul 10, 2013 10-Q 2013-07-29
Q1 2013 124M +931K +0.75% Apr 12, 2013 10-Q 2013-05-01
Q4 2012 124M +1.71M +1.4% Jan 31, 2013 10-K 2013-02-15
Q3 2012 123M +1.94M +1.6% Oct 12, 2012 10-Q 2012-10-29
Q2 2012 123M -1.35M -1.09% Jul 13, 2012 10-Q 2012-07-30
Q1 2012 123M +316K +0.26% Apr 13, 2012 10-Q 2012-05-03
Q4 2011 122M -5.3M -4.15% Jan 31, 2012 10-K 2012-02-24
Q3 2011 121M -3.6M -2.88% Oct 15, 2011 10-Q 2011-11-04
Q2 2011 124M +53.9K +0.04% Jul 15, 2011 10-Q 2011-08-10
Q1 2011 123M Apr 15, 2011 10-Q 2011-05-04
Q4 2010 128M Feb 4, 2011 10-K 2011-02-28
Q3 2010 125M Oct 15, 2010 10-Q 2010-11-05
Q2 2010 124M Jul 15, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.